Furthermore, another gene, ribonucleotide reductase, has been shown to be crucial during the proliferation of cancer cells, and the same applies for VEGF, a variety of their different inhibitors are being used in clinics or undergoing clinical trials for tumor growth inhibition [9,10]. The gene discussed is VEGFA; the disease is neoplasm.